Last updated 2026-07-20
Portfolio
2
in our dataset
Rounds participated
6
Rounds led
0
Rounds' value
$30.2M
total disclosed, rounds participated
Stages
B Round, C Round, Seed, G Round, E Round, D Round, Pre-Seed, A Round, F Round
About
Clal Biotechnology Industries (CBI) is a premier life sciences investment firm listed on the Tel Aviv Stock Exchange (TASE: CBI). CBI specializes in identifying and nurturing groundbreaking ventures that develop proprietary solutions to address unmet medical needs with substantial market potential. Rooted in leading Israeli scientific innovation, its portfolio spans companies at various stages of growth, from seed to maturity, encompassing both private and publicly traded enterprises. CBI's investment portfolio includes biotechnology, pharmaceuticals, diagnostics, and medical devices. The company has offices in Tel Aviv and Boston, providing its portfolio companies access to the global biotechnology industry.
Portfolio · 2
Investment activity
6 portfolio exits on record.
Portfolio by sector
Health Tech & Life Sciences13
Undisclosed4
Agriculture & Food Technologies1
Business Software1
Q&A
- What is Clal Biotechnology Industries' (CBI) primary investment focus?
- Clal Biotechnology Industries (CBI) is a life sciences investment company focused on identifying and supporting innovative ventures developing proprietary solutions for unmet medical needs. Their investments range from biotech and pharma to diagnostics and medical devices.
- Which sectors does Clal Biotechnology Industries (CBI) primarily invest in?
- Clal Biotechnology Industries (CBI) primarily invests in the Health Tech & Life Sciences sector, with 13 portfolio companies in this area. They also have investments in Agriculture & Food Technologies and Business Software.
- Can you name some of Clal Biotechnology Industries' (CBI) notable portfolio companies?
- Clal Biotechnology Industries' (CBI) portfolio includes companies such as TytoCare, which focuses on remote primary care, and Classiq Technologies, a quantum computing software company.
- What is the most recent investment stage Clal Biotechnology Industries (CBI) participated in?
- According to startupim data, Clal Biotechnology Industries (CBI) most recently participated in an investment round in August 2023.
- Has Clal Biotechnology Industries (CBI) had any recent exits?
- Clal Biotechnology Industries (CBI) had an exit in October 2018 when Gamida Cell went public on NASDAQ with a valuation of $210M.
- What is the typical investment stage for Clal Biotechnology Industries (CBI)?
- Clal Biotechnology Industries (CBI) invests in companies ranging from Seed to maturity, including Seed, A Round, B Round, C Round, D Round, E Round, F Round, and G Round.
- Who is the CEO of Clal Biotechnology Industries (CBI)?
- The CEO of Clal Biotechnology Industries (CBI) is Assaf Segal.
- Where is Clal Biotechnology Industries (CBI) headquartered?
- Clal Biotechnology Industries (CBI) is headquartered in Tel Aviv-Yafo, Israel.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | cbi.co.il |
|---|---|
| linkedin.com/company/16215501 |
Identifiers & details
| Legal name | Clal Biotechnology Industries Ltd. |
|---|---|
| Founded | 1993 |
Radar intelligence
Open jobs — bamboohr
| Total open | 2 |
|---|---|
| Remote | 0 |
| By department | Project (direct) (2) |
| By location | Cambridge, Massachusetts (2) |
| Title | Location | Department |
|---|---|---|
| Senior Associate Facilitator/Mediator (Expression of Interest) | Cambridge, Massachusetts | Project (direct) |
| CBI Internship | Cambridge, Massachusetts | Project (direct) |
Web history (Wayback)
| Domain | cbi.co.il |
|---|
Certificate / subdomain footprint
| Subdomains | 15 |
|---|